Search - tctmd.com

Displaying 81 - 100 of 573

Sort: Relevancy | Date

Presentation NY Valves 2025

Is LV Reconstruction a Viable Therapy to Treat the Dilated Heart?

Presenter: Michael I. Brener

June 26, 2025

Presentation NY Valves 2025

Management of Complications in Patient With Narrow LVOT That Can Only Be Treated by Atrial Fixation TMVR

Presenter: Vlasis Ninios

June 25, 2025

Presentation NY Valves 2025

Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR

Presenter: Muhammad Suleman

June 25, 2025

Presentation NY Valves 2025

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

Presenter: Nir Uriel

June 25, 2025

Presentation NY Valves 2025

TEE Guided Transcatheter Closure of LVOT to Left Atrial Fistula via the Aortomitral Curtain After Aortic Bioprosthetic Valve Fracture

Presenter: Amr Mohsen

June 25, 2025

Presentation NY Valves 2025

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Presenter: Anjali Owens

June 25, 2025

Presentation NY Valves 2025

VinMAC Assessing the Risk of LV Outflow Tract Obstruction: CT and 3DEcho

Presenter: Joanna Bartkowiak

June 25, 2025

Presentation THT 2025

Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes: An Analysis of the Society Of Thoracic Surgeons National Intermacs Database

Presenter: Manreet Kanwar

February 13, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 12, 2025

Presentation THT 2025

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Presenter: Kevin John

February 12, 2025

Presentation THT 2025

ARIES Implementation in LVAD Practice

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

DOACS in LVAD: Should We, Should We Not?

Presenter: Palak Shah

February 12, 2025

Presentation THT 2025

Eliminating the Driveline: The Ultimate Solution

Presenter: Melana Yuzefpolskaya

February 12, 2025

Presentation THT 2025

Remote Monitoring in LVAD Patients

Presenter: Gabriel Sayer

February 12, 2025

Presentation THT 2025

Treating Aortic Regurgitation in LVAD Patients - Who, When and How

Presenter: Torsten Vahl

February 12, 2025

Presentation THT 2025

Recovery From Advance HF: Candidate Selection, Durability and Magnitude of Opportunity

Presenter: Stavros Drakos

February 12, 2025

Advertisement

Is LV Reconstruction a Viable Therapy to Treat the Dilated Heart?

Management of Complications in Patient With Narrow LVOT That Can Only Be Treated by Atrial Fixation TMVR

Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR

First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients

TEE Guided Transcatheter Closure of LVOT to Left Atrial Fistula via the Aortomitral Curtain After Aortic Bioprosthetic Valve Fracture

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

VinMAC Assessing the Risk of LV Outflow Tract Obstruction: CT and 3DEcho

Impact of Preoperative Temporary Mechanical Circulatory Support on Durable LVAD Outcomes: An Analysis of the Society Of Thoracic Surgeons National Intermacs Database

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

ARIES Implementation in LVAD Practice

DOACS in LVAD: Should We, Should We Not?

Eliminating the Driveline: The Ultimate Solution

Remote Monitoring in LVAD Patients

Treating Aortic Regurgitation in LVAD Patients - Who, When and How

Recovery From Advance HF: Candidate Selection, Durability and Magnitude of Opportunity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content